RecruitingNCT07338669

Hamburg Acute Renal Injury Study (HARIS)

Hamburg Acute Renal Injury Study


Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

1,000 participants

Start Date

Sep 16, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The Hamburg Acute Renal Injury Study (HARIS) is a prospective observational cohort study aimed at investigating the mechanisms, risk factors, and clinical determinants of acute kidney injury (AKI) trajectories and consequences.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acute kidney injury and acute kidney injury (aki). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07338669


Related Trials